Everence Capital Management Inc. Acquires 2,590 Shares of Certara, Inc. (NASDAQ:CERT)

Everence Capital Management Inc. grew its holdings in Certara, Inc. (NASDAQ:CERT) by 21.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,910 shares of the company’s stock after acquiring an additional 2,590 shares during the quarter. Everence Capital Management Inc.’s holdings in Certara were worth $175,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. The Manufacturers Life Insurance Company lifted its position in Certara by 4.5% in the second quarter. The Manufacturers Life Insurance Company now owns 22,871 shares of the company’s stock worth $317,000 after purchasing an additional 975 shares during the period. Russell Investments Group Ltd. lifted its position in Certara by 1.6% in the first quarter. Russell Investments Group Ltd. now owns 77,753 shares of the company’s stock worth $1,375,000 after purchasing an additional 1,191 shares during the period. Louisiana State Employees Retirement System lifted its position in Certara by 2.3% in the second quarter. Louisiana State Employees Retirement System now owns 54,200 shares of the company’s stock worth $751,000 after purchasing an additional 1,200 shares during the period. Texas Permanent School Fund Corp lifted its position in Certara by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 93,729 shares of the company’s stock worth $1,676,000 after purchasing an additional 1,213 shares during the period. Finally, Blue Trust Inc. bought a new position in Certara in the second quarter worth $26,000. 73.96% of the stock is owned by institutional investors.

Certara Stock Up 0.3 %

Shares of NASDAQ CERT opened at $11.23 on Wednesday. Certara, Inc. has a 52-week low of $10.35 and a 52-week high of $19.87. The stock has a market cap of $1.81 billion, a PE ratio of -28.79, a PEG ratio of 5.40 and a beta of 1.49. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.61 and a current ratio of 2.61. The business has a fifty day moving average of $11.60 and a two-hundred day moving average of $14.33.

Certara (NASDAQ:CERT) last announced its earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Certara had a negative net margin of 21.64% and a positive return on equity of 3.03%. The business had revenue of $93.31 million during the quarter, compared to analyst estimates of $96.01 million. During the same quarter last year, the business posted $0.10 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. As a group, equities research analysts expect that Certara, Inc. will post 0.27 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CERT has been the subject of several research reports. KeyCorp reduced their target price on Certara from $23.00 to $20.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. Robert W. Baird reduced their target price on Certara from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Barclays cut their price objective on Certara from $16.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, October 15th. UBS Group raised Certara from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a report on Friday, September 27th. Finally, JMP Securities reissued a “market perform” rating on shares of Certara in a report on Wednesday, July 10th. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.08.

Insider Activity

In other news, insider Leif E. Pedersen sold 51,224 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $11.29, for a total value of $578,318.96. Following the completion of the sale, the insider now directly owns 99,704 shares in the company, valued at approximately $1,125,658.16. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $11.29, for a total value of $578,318.96. Following the completion of the sale, the insider now directly owns 99,704 shares in the company, valued at $1,125,658.16. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick F. Smith sold 5,409 shares of Certara stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $11.03, for a total value of $59,661.27. Following the completion of the sale, the insider now owns 50,091 shares of the company’s stock, valued at approximately $552,503.73. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.39% of the stock is currently owned by corporate insiders.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.